ELAC2 and cardiomyopathy: Mutations in ELAC2 or deletion of the mouse Elac2 in the heart lead to cardiomyopathies due impaired 3′ tRNA processing that causes loss of mature tRNAs required for translation, consequently resulting in protein synthesis defects and energy dysfunction (Haack et al, 2013; Siira et al, 2018).